327 related articles for article (PubMed ID: 15382115)
1. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.
Nichols MT; Gidey E; Matzakos T; Dahl R; Stiegmann G; Shah RJ; Grantham JJ; Fitz JG; Doctor RB
Hepatology; 2004 Oct; 40(4):836-46. PubMed ID: 15382115
[TBL] [Abstract][Full Text] [Related]
2. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease.
Wilson PD; Du J; Norman JT
Eur J Cell Biol; 1993 Jun; 61(1):131-8. PubMed ID: 8223698
[TBL] [Abstract][Full Text] [Related]
3. CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.
Amura CR; Brodsky KS; Gitomer B; McFann K; Lazennec G; Nichols MT; Jani A; Schrier RW; Doctor RB
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C786-96. PubMed ID: 18199703
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
Wang W; Mei C; Tang B; Zhao H; Xu C; Li Z; Shen X; Fu W; Dai B
Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
[TBL] [Abstract][Full Text] [Related]
5. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
Amura CR; Brodsky KS; Groff R; Gattone VH; Voelkel NF; Doctor RB
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
Elberg D; Jayaraman S; Turman MA; Elberg G
Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
[TBL] [Abstract][Full Text] [Related]
8. EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells.
Elberg G; Elberg D; Lewis TV; Guruswamy S; Chen L; Logan CJ; Chan MD; Turman MA
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1622-32. PubMed ID: 17728378
[TBL] [Abstract][Full Text] [Related]
9. Liver cyst cytokines promote endothelial cell proliferation and development.
Brodsky KS; McWilliams RR; Amura CR; Barry NP; Doctor RB
Exp Biol Med (Maywood); 2009 Oct; 234(10):1155-65. PubMed ID: 19596832
[TBL] [Abstract][Full Text] [Related]
10. Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia.
Wilson PD; Hreniuk D; Gabow PA
J Cell Physiol; 1992 Feb; 150(2):360-9. PubMed ID: 1734038
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.
Kanaan N; Goffin E; Pirson Y; Devuyst O; Hassoun Z
Am J Kidney Dis; 2010 May; 55(5):916-22. PubMed ID: 20189277
[TBL] [Abstract][Full Text] [Related]
12. Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease.
Kenter AT; van Rossum-Fikkert SE; Salih M; Verhagen PCMS; van Leenders GJLH; Demmers JAA; Jansen G; Gribnau J; Zietse R; Hoorn EJ
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F204-F213. PubMed ID: 30403162
[TBL] [Abstract][Full Text] [Related]
13. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
[TBL] [Abstract][Full Text] [Related]
14. Basolateral chloride transporters in autosomal dominant polycystic kidney disease.
Lebeau C; Hanaoka K; Moore-Hoon ML; Guggino WB; Beauwens R; Devuyst O
Pflugers Arch; 2002 Sep; 444(6):722-31. PubMed ID: 12355171
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.
Zheng D; Wolfe M; Cowley BD; Wallace DP; Yamaguchi T; Grantham JJ
J Am Soc Nephrol; 2003 Oct; 14(10):2588-95. PubMed ID: 14514736
[TBL] [Abstract][Full Text] [Related]
16. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
[TBL] [Abstract][Full Text] [Related]
17. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
[TBL] [Abstract][Full Text] [Related]
18. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks.
Song X; Di Giovanni V; He N; Wang K; Ingram A; Rosenblum ND; Pei Y
Hum Mol Genet; 2009 Jul; 18(13):2328-43. PubMed ID: 19346236
[TBL] [Abstract][Full Text] [Related]
19. Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures.
Elberg G; Guruswamy S; Logan CJ; Chen L; Turman MA
Cell Tissue Res; 2008 Feb; 331(2):495-508. PubMed ID: 18004594
[TBL] [Abstract][Full Text] [Related]
20. Evidence for inflammatory and secretagogue lipids in cyst fluids from patients with autosomal dominant polycystic kidney disease.
Grantham JJ; Schreiner GF; Rome L; Grenz L; Joly A
Proc Assoc Am Physicians; 1997 Jul; 109(4):397-408. PubMed ID: 9220537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
